HOME >> BIOLOGY >> NEWS
Jefferson scientists show drug is effective against a Hepatitis C Virus model in the laboratory

Glucosidase inhibitors may have a future as broad-based hepatitis drugs Researchers at Jefferson Medical College may have found a promising drug against the hepatitis C virus (HCV). While they are quick to point out that the drug, N-nonyl-DNJ, stopped only a surrogate virus - and not the actual HCV - from reproducing in the laboratory, they believe the findings, which build on their earlier success against hepatitis B virus (HBV), may someday lead to a single drug against both viruses.

Timothy Block, Ph.D., professor of biochemistry and molecular pharmacology and medicine at Thomas Jefferson University in Philadelphia, and colleagues at Oxford University in Oxford, UK, used the drug to inhibit the activity of an important cellular enzyme, glucosidase. This in turn prevented the bovine diarrhea virus, BVDV, which is a tissue culture model of HCV, from making more virus. Dr. Block believes this class of drugs, called glucosidase inhibitors, "have a reasonable likelihood of working against HCV therapeutically." Because HCV cannot be grown in the lab, researchers use BVDV as a testing model.

"This is the first drug since alpha-interferon to my knowledge for which there is published experimental evidence against HCV - in the form of BVDV susceptibility," says Dr. Block, who is a member of Jefferson's Kimmel Cancer Center and director of the Jefferson Center for Biomedical Research and Agricultural Medicine.

The drug may sidestep resistant viruses, the bane of current anti-hepatitis treatments. "Since the drugs target a host cellular enzyme at very non-toxic doses, rather than the virus, we think that resistance to the drugs will not be a problem,"he says.

The findings appear Oct. 12 in the Proceedings of the National Academy of Sciences. Viruses such as HCV, HBV and BVDV reproduce by actually "budding out from intracellular membranes." The viruses
'"/>

Contact: Steve Benowitz
steven.benowitz@mail.tju.edu
215-955-5291
Thomas Jefferson University
11-Oct-1999


Page: 1 2 3

Related biology news :

1. Jefferson Lab detector technology aids development of cystic fibrosis therapy
2. Jefferson scientists find gene expression pattern may predict behavior of leukemia
3. Jefferson researchers develop microchip to track genetic signature of cancer and normal tissue
4. Jefferson scientists use gene therapy to restore function of damaged heart cells in lab
5. Jefferson researchers uncover biochemical clues to how cells migrate in embryos
6. Jefferson and Brigham and Womens researchers find blue light important for setting biological clock
7. Jefferson Lab experiment generates THz radiation 20,000 times brighter than anyone else
8. Jefferson scientists show neural stem cells can become dopamine-making brain cells in laboratory
9. Jefferson scientists show how collagen gene mutation leads to osteoarthritis
10. Jefferson scientists use gene repair technique to change albino mice hairs to black
11. Jefferson scientists propose mechanism to control the bodys red blood cell and platelet production

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/9/2019)... Md. (PRWEB) , ... November ... ... with Alizée Pathology to form the leading provider of specialized histology, pathology, ... research industries. StageBio was recently created by the mergers of Histo-Scientific Research ...
(Date:11/6/2019)... ... November 06, 2019 , ... In October, Massachusetts stem cell ... patients about a poorly disclosed deficiency in stem cell treatments. Throughout stem ... the treating stem cells. This problem affects all patients receiving stem cell ...
(Date:11/5/2019)... ... November 05, 2019 , ... Dr. ... and restorative dentistry to Seattle, WA, including porcelain veneers , smile makeovers, ... from the University of Washington, Dr. Kopp is passionate about serving her Seattle ...
Breaking Biology News(10 mins):
(Date:10/29/2019)... ... October 29, 2019 , ... Modality Solutions, a ... cold chain validation workshop at the Biomanufacturing World Summit (BMWS19) Conference, November 11-12, ... The Biomanufacturing World Summit brings together pharmaceutical executives, cutting-edge technology providers, ...
(Date:10/22/2019)... ... October 22, 2019 , ... Catalent, a global leader ... and Drug Product Technologies Integration, will participate in a panel session titled “Cell and ... be held at the Gwen Hotel, Chicago, on Oct. 28-30, 2019. , The panel ...
(Date:10/17/2019)... ... October 16, 2019 , ... My Gene ... information, has published a new white paper that explores how frequently medical management ... to how patients and medical providers can be kept informed as changes are ...
(Date:10/10/2019)... ... ... R3 Stem Cell announces it has added an exosome presentation to its ... with spots still open. , The speaker, Dr. Ian White PhD, is a world ... Harvard and Dartmouth. He currently serves as the Chief Scientific Officer at IMAC Regeneration ...
Breaking Biology Technology:
Cached News: